Brain Tumor Therapeutics Market To Grow At 11.1% CAGR Through 2030

2025-12-12 10:31:26

(MENAFN- GlobeNewsWire - Nasdaq) "Innovative Therapies and AI-Driven Immunotherapy Lead the Charge in Overcoming the Blood-Brain Barrier and Transforming the Brain Tumor Treatment Landscape"

Boston, Dec. 12, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research,“ Brain Tumor Therapeutics: Global Markets to 2030

This report offers a comprehensive look at the brain tumor therapeutics market, highlighting its current status and future potential. It is segmented by therapy type (chemotherapy, targeted therapy, immunotherapy), patient age (adult and pediatric), and end users (hospitals and home care settings). The analysis spans major global regions and key countries, examining market drivers, restraints, regulatory scenarios, and competitive dynamics. It also evaluates the market shares of leading companies and identifies long-term opportunities and challenges in the industry.

This report is especially relevant now as the brain tumor therapeutics industry is undergoing a transformative shift. Breakthroughs in immunotherapy, targeted treatments, and advanced drug delivery systems are redefining how brain tumors are treated. Promising clinical trial results and recent FDA approvals, particularly for pediatric and central nervous system cancers, highlight a rapidly evolving landscape. Understanding the intersection of innovation, cost effectiveness, and patient accessibility is crucial for stakeholders aiming to navigate and capitalize on this dynamic market.

The factors driving the market's growth include:

Increasing Incidence of Brain Tumor Cases: The global rise in brain tumor diagnoses, especially among aging populations, is driving demand for advanced treatments. Improved imaging and diagnostic tools are also contributing to higher detection rates, making therapeutic solutions more essential than ever.

Increasing R&D Spending by Market Players: Pharmaceutical and biotech companies are investing in brain tumor research, focusing on innovative therapies like gene editing, immunotherapy, and AI-driven drug development. This surge in R&D is expanding the treatment pipeline and accelerating clinical advances.

Rise in Government Funding and Pharmaceutical R&D Spending: Governments worldwide are boosting funding for brain tumor research through grants, infrastructure support, and fast-track regulatory approvals. Combined with private sector investment, this is fostering innovation and improving access to cutting-edge therapies.

Request a sample copy of the global market for brain tumor therapeutics report

Report Synopsis

Report Metric	Details
Base year considered	2024
Forecast period considered	2025-2030
Base year market size	$2.5 billion
Market size forecast	$4.7 billion
Growth rate	CAGR of 11.1% for the forecast period of 2025-2030
Segments covered	Therapy Type, Patient Age, End User, Region
Regions covered	North America, Europe, Asia-Pacific, South America, Rest of the World
Countries covered	U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, Austria, Denmark, the Netherlands, Poland, Sweden, Switzerland, China, Japan, South Korea, India, Australia, Malaysia, New Zealand, Singapore, Thailand, Vietnam, Brazil, Argentina, Rest of South America, Argentina, Brazil, Colombia, Paraguay, Peru, Middle East and Africa
Market Drivers	Increasing Incidence of Brain Tumor Cases Increasing R&D Spending by Market Players Rise in Government Funding and Pharmaceutical R&D Spending

Interesting facts:

Innovative Delivery Methods: Due to the challenges posed by the blood-brain barrier and the aggressive nature of brain tumors, researchers are exploring unconventional therapeutic delivery methods such as focused ultrasound, engineered nanoparticles, and immune cell-based "Trojan horses" to directly target tumor sites.

Therapeutic Innovation Potential: These novel approaches highlight the unique potential for therapeutic innovation in the brain tumor treatment industry, aiming to overcome traditional limitations and improve treatment efficacy.

The report addresses the following questions:

What are the projected size and growth rate of the market?

The global market for brain tumor therapeutics was valued at $2.5 billion in 2024 and is projected to reach $4.7 billion by the end of 2030. The market is expected to grow at a CAGR of 11.1% during the forecast period.

What factors are driving the growth of the market?

The increasing incidence of brain tumor and research collaborations were reviewed to understand the market dynamics and trends for forecasting the market size.

What are the challenges and opportunities of the market?

Market restraints such as inadequate treatment options for brain tumors and the high cost of brain cancer drugs, were reviewed to understand the market dynamics and trends for forecasting the market size. In contrast, the opportunities in the market include rising competition from generics.

What market segments are covered in the report?

The brain tumor therapeutics market is segmented by therapy type into chemotherapy, targeted therapy and immunotherapy. The patient age market is segmented into adults and pediatrics. End users include hospitals and home care settings.

Which therapy type will be dominant through 2030?

Chemotherapy is the dominant type of therapy in brain tumor therapeutics.

Which region has the largest market share?

North America accounted for 56.7% of the global market for brain tumor therapeutics in 2024.

Market leaders include:

AMGEN INC.
AMNEAL PHARMACEUTICALS LLC.
BAXTER
BAYER AG
F. HOFFMANN-LA ROCHE LTD.
MERCK & CO. INC.
NOVARTIS AG
PFIZER INC.
SERVIER LABORATORIES
TEVA PHARMACEUTICAL INDUSTRIES LTD.

Related Reports:

Anti-Parkinson's Drugs: Global Markets to 2030: The report provides a comprehensive analysis of the global anti-Parkinson's drugs market, highlighting trends, challenges, and growth projections. The market is segmented by drug class including dopaminergic agents, dopamine agonists, COMT inhibitors, MAO B inhibitors, anticholinergics, and others, and by region covering North America, Europe, Asia Pacific, the Middle East and Africa, and South America. It also explores ESG developments, emerging technologies, and the competitive landscape, with detailed company profiles including financials, product portfolios, and recent developments.

Biologic Therapeutic Drugs: Technologies and Global Markets

Purchase a copy of the report direct from BCC Research.

For further information on any of these reports or to make a purchase, contact....

About BCC Research

BCC Research market research reports provide objective, unbiased measurement and assessment of market opportunities. Our experienced industry analysts' goal is to help you make informed business decisions free of noise and hype.

For media inquiries, email... or visit our media page for access to our market research library.

Any data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher.
CONTACT: BCC Research Corporate HQ: 50 Milk St. Ste 16, Boston, MA 02109, U.S. Email:... Phone: +1 781-489-7301
MENAFN12122025004107003653ID1110472929

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.